Bad News Bears Flee Trading Tsunami
After an initial sense of relief when the debt deal started coming together Monday morning, markets have slumped back in their figurative armchair to watch a series of economic debacles unfold like bad TV
Home » Equities
Equities
Graphic Evidence: OceanFreight Rides 79% Wave
While the masses clamor to get in the upcoming IPOs of bubbly hot-tech companies, it might pay off to avoid the IPO thrill-seeking crowd and strap on an unglamorous, but undervalued, shipping stock.
A Day of Reckoning for Netflix?
Being short Netflix (NFLX) has been a risky, if not foolish, proposition for quite a while now. That sentiment aside, Netflix committed the cardinal sin for a richly valued tech stock after the close of U.S. markets Monday by guiding lower on third-quarter profits and revenue.
Graphic Evidence: High Noon for NEWN?
New Energy Systems Group (NEWN) stock soared 70.87% Tuesday to close at $3.93, apparently on news that it is introducing three new portable recharging devices for laptops and tablet personal computers.
The President Is Not a Winner to Casino Mogul
There are a few things that are obvious about Wynn Resorts (WYNN) founder and CEO Steve Wynn. He knows how to make money for shareholders. He likes to adorn his hotels with some pricey furnishings. And he sure isn’t a fan of President Barack Obama.
Graphic Evidence: Code Blue for WebMD?
WebMD’s stock plunged about 30% and then flatlined around $32 Monday after the company lowered revenue guidance. It remains to be seen whether WebMD deserved the pummeling it took in a matter of minutes after releasing guidance numbers.
Traders Embrace Netflix Hike, Customers Boiling Mad
Netflix (NFLX), the provider of online streaming movie services and DVDs by mail, has once again found a way to keep its name in the news and irk its customers.
Graphic Evidence: Immucor Hops M&A Train
Shares of in vitro diagnostics specialist Immucor Inc. (BLUD) blasted up 30.2% to close at $26.99 Tuesday on news of a transaction that would make the company privately held.
Graphic Evidence: Pfizer Filing Ignites Icagen
Takeover rumors are usually a good pop. But more than 160% in one day?
Paulson Defends Sino-Forest Investment
No one is perfect, and that is a lesson John Paulson learned this month as his firm’s position in controversial Chinese-Canadian timber firm Sino-Forest basically blew up in the New York firm’s face.
